Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Change

16 Oct 2019 16:11

RNS Number : 1333Q
Cenkos Securities PLC
16 October 2019
 

16 October 2019

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 ("MAR").

 

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Directorate Change

 

The Board of Cenkos is pleased to announce the appointment of Julian Morse, as an Executive Director of the Company. This appointment is subject to Financial Conduct Authority approval and will take effect on the receipt of regulatory consent.

 

Julian is Head of the Cenkos Growth Companies Team and has led that team since 2016. He is one of the founding members of the team having joined Cenkos in 2006. He has over 25 years' experience in the City where he has advised and raised equity on IPO's and secondary fund raisings for a wide range of companies across a broad range of sectors. Previously, Julian was a Director at Beeson Gregory and Evolution Securities.

Commenting on the appointment, Jeff Hewitt Acting Chairman of the Company, said:

"I am delighted that Julian has agreed to join the Board. With Julian's experience and proven success in managing the Growth Companies team he will provide a valuable addition to the Board and will assist in driving the whole business forward."

Additional Information

 

In accordance with the AIM Rules, the following information is required to be disclosed in relation to Julian Morse is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full Name and age:

Julian Jonathan Morse aged 48

 

Current Directorships/Partnerships:

None

 

Previous Directorships/Partnerships:

Dovemoat LLP - LLP member resigned 17 November 2015

 

Current interest in the Company's share capital:

403,239 Ordinary shares of 1 pence held under his Self-Invested Personal Pension

384,501 Ordinary shares of 1 pence held in accordance with the terms and conditions of Company's Deferred Bonus Scheme

18,842 Ordinary shares of 1 pence shares held in the Company's Share Incentive Plan of which X are subject to forfeiture

 

Options over 185,220 Ordinary shares held under the Compensatory Award Plan Options. These options are at 169.0 pence. These options expire on 22 October 2019.

 

Options over 21,094 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 85.3 pence. These options expire on 30 November 2021.

 

 

 

 

Enquiries:

 

Cenkos Securities plc

Jim Durkin, Chief Executive Officer

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

Tel: 0207 466 5066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABUBDGRGBBGCL
Date   Source Headline
11th May 201710:24 amRNSForm 8.5 (EPT/NON-RI)
3rd May 20179:45 amRNSForm 8.5 (EPT/NON-RI)
2nd May 201710:38 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 201710:09 amRNSForm 8.5 (EPT/NON-RI)
25th Apr 201710:10 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20179:30 amRNSForm 8.5 (EPT/NON-RI)
18th Apr 20177:00 amRNSBlock listing Interim Review
13th Apr 201710:05 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 20175:43 pmRNSDirector/PDMR Shareholding
12th Apr 20175:35 pmRNSDirector/PDMR Shareholding
11th Apr 201710:35 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201710:18 amRNSForm 8.5 (EPT/NON-RI)
7th Apr 20174:10 pmRNSAnnual Report and Notice of AGM
4th Apr 201712:07 pmRNSDirectorate Change
4th Apr 201710:26 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 201710:04 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20179:58 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20177:00 amRNSFinal Results
30th Mar 201711:06 amRNSForm 8.5 (EPT/NON-RI)
29th Mar 201710:01 amRNSForm 8.5 (EPT/NON-RI)
28th Mar 201710:43 amRNSForm 8.5 (EPT/NON-RI)
27th Mar 201710:17 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201711:18 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 201711:15 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201710:29 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 201710:14 amRNSForm 8.3 - BowLeven Plc
17th Mar 201711:16 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 201710:51 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 201710:08 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 20179:32 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 201710:17 amRNSForm 8.5 (EPT/NON-RI)
9th Mar 20179:40 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 201710:14 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 201710:03 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 201610:51 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 20169:52 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 201611:10 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 201611:24 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 201612:05 pmRNSForm 8.5 (EPT/NON-RI)
12th Dec 201611:24 amRNSForm 8.5 (EPT/NON-RI)
9th Dec 20169:59 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20169:46 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201610:50 amRNSForm 8.5 (EPT/NON-RI)
25th Nov 20169:49 amRNSForm 8.5 (EPT/NON-RI)
24th Nov 20169:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20167:00 amRNSDirectorate Change
18th Nov 201612:07 pmRNSForm 8.5 (EPT/NON-RI)
16th Nov 20169:47 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 201610:11 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20169:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.